Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials

Detalles Bibliográficos
Autores principales: Li, Guangyao, Crowley, Matthew J., Tang, Huilin, Yang, Jeff Y., Sandler, Robert S., Wang, Tiansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2019
Materias:
e-Letters: Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118251/
https://www.ncbi.nlm.nih.gov/pubmed/31221707
http://dx.doi.org/10.2337/dc18-1578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118251/
https://www.ncbi.nlm.nih.gov/pubmed/31221707
http://dx.doi.org/10.2337/dc18-1578

Ejemplares similares